
Theratechnologies THTX
Annual report 2024
added 03-21-2026
Theratechnologies Cash Conversion Cycle 2011-2026 | THTX
Annual Cash Conversion Cycle Theratechnologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 178 | 568 | 923 | 1.63 K | 1.02 K | - | 61.2 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 61.2 K | 178 | 10.9 K |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
ACADIA Pharmaceuticals
ACAD
|
257 | $ 22.56 | 2.13 % | $ 3.74 B | ||
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Akebia Therapeutics
AKBA
|
42 | $ 1.43 | 3.62 % | $ 368 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
46.6 | $ 327.25 | 2.42 % | $ 42.9 B | ||
|
Autolus Therapeutics plc
AUTL
|
119 | $ 1.49 | 9.56 % | $ 397 M | ||
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
205 | $ 20.4 | -0.87 % | $ 954 M | ||
|
Aquestive Therapeutics
AQST
|
-172 | $ 4.18 | 1.21 % | $ 447 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
174 | $ 2.66 | 3.5 % | $ 16.7 M | ||
|
AstraZeneca PLC
AZN
|
-58 | - | - | $ 96.9 B | ||
|
Arcutis Biotherapeutics
ARQT
|
158 | $ 24.61 | 5.76 % | $ 3.13 B | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
Avid Bioservices
CDMO
|
85.5 | - | - | $ 789 M | ||
|
Cidara Therapeutics
CDTX
|
2.26 K | - | - | $ 1.41 B | ||
|
AIkido Pharma
AIKI
|
-1.92 | - | 1.93 % | $ 17.4 M | ||
|
Celldex Therapeutics
CLDX
|
-3.74 K | $ 32.41 | 3.38 % | $ 2.15 B | ||
|
Chimerix
CMRX
|
588 | - | - | $ 756 M |